Hittel, Norbert
Lazarevic, Natasa
Martin, Alexandra
Schorn, Britta
Leporowski, Axel
Zhang, Vivian
George, Vinu
van Heumen, Emiel
Article History
Received: 27 September 2025
Accepted: 19 January 2026
First Online: 12 February 2026
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article. Norbert Hittel, Natasa Lazarevic and Alexandra Martin are employees of Otsuka Novel Products GmbH (ONPG). Britta Schorn, Axel Leporowski and Emiel van Heumen. are employees of Otsuka Pharma GmbH, Frankfurt, Germany. Vivian Zhang and Vinu George are employees of Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. No identifiable information about individuals was disclosed in the manuscript and all findings are reported in aggregated form.